Mechanisms of SIRT2 Function in the Replication Stress Response

SIRT2在复制应激反应中的作用机制

• 批准号: 8766965
• 负责人: David Sung-wen Yu
• 金额: $ 7.26万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-01 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8766965
• 关键词: Acetylation; Address; Aging; B-Lymphocytes; BRCA2 gene; Biological Markers; CDK9 Protein Kinase; Cell Cycle Arrest; Cell Cycle Checkpoint; Cell Survival; Cells; DNA Damage; DNA Repair; DNA Replication Damage; DNA biosynthesis; Data; Deacetylase; Deacetylation; Development; Disease; Family; Genetic; Genome; Genomic Instability; Goals; Human; Impairment; In Vitro; Ionizing radiation; Knowledge; Link; Lysine; MCM3 gene; Malignant Neoplasms; Malignant neoplasm of liver; Maps; Mass Spectrum Analysis; Mediating; Mus; Mutation; Pathway interactions; Phenotype; Play; Premature aging syndrome; Prevention; Process; Proteins; Recovery; Regulation; Research; Research Proposals; Resistance; Role; Signal Pathway; Signal Transduction; Sirtuins; Site; Stress; Testing; Therapeutic; Tumor Suppression; Tumor Suppressor Proteins; Work; anticancer research; biological adaptation to stress; cancer prevention; cancer therapy; carcinogenesis; coping; design; improved; innovation; insight; malignant breast neoplasm; member; neoplastic cell; novel; prevent; public health relevance; response; scaffold; tumor

DESCRIPTION (provided by applicant): Accurate replication of the genome and continuous surveillance of its integrity are essential for cell survival and avoidance of diseases such as cancer and premature aging. The replication stress response (RSR) recognizes challenges to DNA replication from insults such as ionizing radiation and coordinates diverse DNA repair and cell cycle checkpoint pathways necessary to maintain genome integrity. However, the mechanisms mediating many RSR activities and how their dysregulation leads to carcinogenesis are poorly understood. Thus, the overarching goal of this proposal is to determine the critical processes by which cells respond to replication stress and apply this knowledge for cancer prevention and treatment. Preliminary data identify SIRT2, a sirtuin family deacetylase, as a novel regulator of the RSR. Prior work has implicated sirtuins in both aging and tumor suppression. Specifically, mice deficient in Sirt2 develop breast and liver cancers, and SIRT2 expression is decreased in human breast and liver cancers, suggesting that SIRT2 is a legitimate tumor suppressor. Recent data from the lab show that SIRT2 deacetylates CDK9 at a conserved lysine residue to promote recovery from replication arrest. Mass spectrometry approaches also identified a number of additional RSR proteins that interact with and are deacetylated by SIRT2. These findings imply a critical role for SIRT2 in the RSR that may provide an underlying mechanism by which aging and carcinogenesis are connected; however, the precise functions of SIRT2 in the RSR are not clear. As such, the overall objective of this proposal is to determine the mechanisms by which SIRT2 functions in the RSR to maintain genome integrity. The hypothesis being tested is that SIRT2 maintains genome integrity, at least in part, by directing the RSR through deacetylation of CDK9 and other key substrates. The following specific aims are proposed: 1. Determine and mechanistically dissect the specific role that SIRT2 plays in directing the RSR, 2. Determine the functional significance of SIRT2-mediated deacetylation of CDK9 in the RSR, 3. Identify SIRT2 substrates that function in the RSR. This proposal is conceptually innovative in that it proposes a novel mechanism for regulation of the RSR that involves SIRT2 as an orchestrator of the RSR through deacetylation of critical RSR proteins, establishing a novel paradigm by which RSR proteins are regulated by deacetylation and establishing a novel role for SIRT2, and more generally for sirtuins, in the regulation of the RSR. Completion of these aims will provide new insights into how SIRT2 maintains genome integrity and prevents cancer, elucidate the significance of the SIRT2 acetylome in regulating the RSR, and improve our understanding of the link between aging and carcinogenesis. Recently, the NCI has proposed a new research emphasis to design rigorous and innovative research strategies to solve specific problems and paradoxes in cancer research identified as the NCI's "Provocative Questions." This research proposal addresses one such question "What mechanisms of aging, beyond the accumulation of mutations, promote or protect against cancer development?"

描述（由申请人提供）：基因组的准确复制及其完整性的持续监测对于细胞存活和避免疾病（如癌症和过早衰老）至关重要。复制应激反应（RSR）识别来自电离辐射等损伤对DNA复制的挑战，并协调维持基因组完整性所必需的多种DNA修复和细胞周期检查点途径。然而，介导许多RSR活动的机制以及它们的失调如何导致致癌作用还知之甚少。因此，该提案的总体目标是确定细胞对复制压力做出反应的关键过程，并将这些知识应用于癌症预防和治疗。初步数据鉴定SIRT 2，sirtuin家族脱乙酰酶，作为RSR的新调节剂。先前的工作涉及sirtuins在衰老和肿瘤抑制。具体来说，Sirt 2缺陷的小鼠会患乳腺癌和肝癌，而SIRT 2在人类乳腺癌和肝癌中的表达会降低，这表明SIRT 2是一种合理的肿瘤抑制因子。来自实验室的最新数据表明，SIRT 2在保守的赖氨酸残基处使CDK 9脱乙酰化，以促进从复制停滞中恢复。质谱法还鉴定了许多与SIRT 2相互作用并被SIRT 2脱乙酰化的其他RSR蛋白。这些发现暗示了SIRT 2在RSR中的关键作用，这可能提供了一种将衰老和致癌联系起来的潜在机制;然而，SIRT 2在RSR中的确切功能尚不清楚。因此，本提案的总体目标是确定SIRT 2在RSR中发挥功能以维持基因组完整性的机制。正在测试的假设是SIRT 2至少部分地通过指导RSR通过CDK 9和其他关键底物的脱乙酰化来维持基因组完整性。提出了以下具体目标：1。确定并机械地剖析SIRT 2在指导RSR中发挥的具体作用，2。确定SIRT 2介导的CDK 9去乙酰化在RSR中的功能意义，3.鉴定在RSR中起作用的SIRT 2底物。该提议在概念上是创新的，因为它提出了一种新的RSR调节机制，该机制涉及SIRT 2作为RSR的协调者，通过关键RSR蛋白的脱乙酰化，建立了一种新的范式，通过该范式RSR蛋白通过脱乙酰化进行调节，并建立了SIRT 2的新作用，更一般地说是sirtuins在RSR调节中的作用。这些目标的完成将为SIRT 2如何保持基因组完整性和预防癌症提供新的见解，阐明SIRT 2乙酰组在调节RSR中的重要性，并提高我们对衰老和致癌之间联系的理解。最近，NCI提出了一个新的研究重点，即设计严格和创新的研究策略，以解决癌症研究中的特定问题和悖论，被NCI称为“挑衅性问题”。这项研究提案解决了这样一个问题：“除了突变的积累，衰老的机制是什么，促进或防止癌症的发展？”"